These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 1764812)
21. Effects of enalapril on the expression of cardiac angiotensin-converting enzyme and angiotensin-converting enzyme 2 in spontaneously hypertensive rats. Yang Z; Yu X; Cheng L; Miao LY; Li HX; Han LH; Jiang WP Arch Cardiovasc Dis; 2013 Apr; 106(4):196-201. PubMed ID: 23706365 [TBL] [Abstract][Full Text] [Related]
22. Renal responses to angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor in partially nephrectomized spontaneously hypertensive rats. Okada H; Suzuki H; Kanno Y; Ikenaga H; Saruta T J Cardiovasc Pharmacol; 1995 Oct; 26(4):564-9. PubMed ID: 8569216 [TBL] [Abstract][Full Text] [Related]
23. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats. De Godoy MA; Rattan S J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368 [TBL] [Abstract][Full Text] [Related]
24. Renin and angiotensinogen gene expression and intrarenal renin distribution during ACE inhibition. Gomez RA; Lynch KR; Chevalier RL; Everett AD; Johns DW; Wilfong N; Peach MJ; Carey RM Am J Physiol; 1988 Jun; 254(6 Pt 2):F900-6. PubMed ID: 2837909 [TBL] [Abstract][Full Text] [Related]
25. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response? van den Meiracker AH; Man in 't Veld AJ; Admiraal PJ; Ritsema van Eck HJ; Boomsma F; Derkx FH; Schalekamp MA J Hypertens; 1992 Aug; 10(8):803-12. PubMed ID: 1325513 [TBL] [Abstract][Full Text] [Related]
26. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats. Makino N; Sugano M; Otsuka S; Hata T Hypertension; 1997 Oct; 30(4):796-802. PubMed ID: 9336375 [TBL] [Abstract][Full Text] [Related]
27. Short- and long-term effects of spirapril on renal hemodynamics in patients with essential hypertension. Reams GP; Lau A; Knaus V; Bauer JH J Clin Pharmacol; 1993 Apr; 33(4):348-53. PubMed ID: 8473550 [TBL] [Abstract][Full Text] [Related]
28. Augmented diurnal variations of the cardiac renin-angiotensin system in hypertensive rats. Naito Y; Tsujino T; Fujioka Y; Ohyanagi M; Iwasaki T Hypertension; 2002 Dec; 40(6):827-33. PubMed ID: 12468565 [TBL] [Abstract][Full Text] [Related]
29. Short-term treatment of stroke-prone spontaneously hypertensive rats with an AT1 receptor blocker protects against hypertensive end-organ damage by prolonged inhibition of the renin-angiotensin system. Hamaguchi R; Takemori K; Inoue T; Masuno K; Ito H Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1151-5. PubMed ID: 18518883 [TBL] [Abstract][Full Text] [Related]
30. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats. Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697 [TBL] [Abstract][Full Text] [Related]
31. Intrarenal Renin-Angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis. Graciano ML; Cavaglieri Rde C; DellĂȘ H; Dominguez WV; Casarini DE; Malheiros DM; Noronha IL J Am Soc Nephrol; 2004 Jul; 15(7):1805-15. PubMed ID: 15213268 [TBL] [Abstract][Full Text] [Related]
32. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats. Paull JR; Widdop RE J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847 [TBL] [Abstract][Full Text] [Related]
33. Effect of chronic captopril treatment on circulating and tissue renin-angiotensin system in SHR rats. Hu WY; Chen DG; Chen SC; Jin XQ; Wang HJ Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):507-12. PubMed ID: 9863143 [TBL] [Abstract][Full Text] [Related]
34. Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus. Tikkanen T; Tikkanen I; Rockell MD; Allen TJ; Johnston CI; Cooper ME; Burrell LM Hypertension; 1998 Oct; 32(4):778-85. PubMed ID: 9774379 [TBL] [Abstract][Full Text] [Related]
35. The persistent effect of long-term enalapril on pressure natriuresis in spontaneously hypertensive rats. Dukacz SA; Adams MA; Kline RL Am J Physiol; 1997 Jul; 273(1 Pt 2):F104-12. PubMed ID: 9249597 [TBL] [Abstract][Full Text] [Related]
36. Tissue-specific regulation of type 1 angiotensin II receptor mRNA levels in the rat. Sechi LA; Griffin CA; Giacchetti G; Valentin JP; Llorens-Cortes C; Corvol P; Schambelan M Hypertension; 1996 Sep; 28(3):403-8. PubMed ID: 8794824 [TBL] [Abstract][Full Text] [Related]
37. A nonpeptide, piperidine renin inhibitor provides renal and cardiac protection in double-transgenic mice expressing human renin and angiotensinogen genes. Major TC; Olszewski B; Rosebury W; Okerberg C; Carlson T; Ostroski R; Schroeder R; Kowala MC; Leadley R Cardiovasc Drugs Ther; 2008 Dec; 22(6):469-78. PubMed ID: 18679781 [TBL] [Abstract][Full Text] [Related]
38. [Angiotensin-converting enzyme inhibition: direct and indirect mechanisms]. Stumpe KO Klin Wochenschr; 1985 Sep; 63(18):897-906. PubMed ID: 2997540 [TBL] [Abstract][Full Text] [Related]
39. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure]. Ciechanowicz A Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103 [TBL] [Abstract][Full Text] [Related]
40. Influence of captopril treatment on angiotensin II receptors and angiotensinogen in the brain of spontaneously hypertensive rats. Schelling P; Felix D Hypertension; 1983; 5(6):935-42. PubMed ID: 6317552 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]